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Introduction The routine practice of neck dissection in the surgical management of
oral carcinoma has evolved into a more functionally conservative approach. Over time,
the rationale for removal of the submandibular gland has been questioned. Routine
extirpation of the submandibular gland can aggravate the xerostomia experienced by
many patients, signiﬁcantly affecting their quality of life.
Objective The objective of the present study was to determine the incidence of
submandibular gland metastases in oral cavity carcinoma and to identify possible
factors that may affect their involvement.
Methods A total of 149 cases of oral carcinoma presenting at a private tertiary care
hospital in Karachi, Pakistan, over the course of 1 year were reviewed retrospectively.
Results Histopathological data showed that the submandibular gland was involved in
7 (4.7%) cases. Involvement of level I lymph nodes was found in all of the cases. Direct
extension of primary tumor was noted in two cases when the primary tumor was in the
ﬂoor of the mouth.
Conclusion The results suggest that preservation of the submandibular gland during neck
dissection for oral carcinoma can be practiced safely when there is no evidence of direct
extension of the primary tumor toward the submandibular gland or when there is no clinical
or radiological evidence of neck disease in level I. Presence of pathological lymph nodes in
level I requires caution when contemplating preservation of the submandibular gland.
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Introduction
Over time, the routine practice of neck dissection in the surgical
management of oral carcinoma has moved toward a more
functionally conservative approach. The earliest description
of radical neck dissection as proposed by Crile1 has been
replaced with selective cervical lymphadenectomy, addressing
the earliest nodal basins and conservation of nonlymphatic
structures like the sternocleidomastoid muscle, the internal
jugular vein and the spinal accessory nerve. This is the result of
an improved understanding of cervical nodal metastasis and the
prognostic evidence supporting a conservative procedure.2–4
Removal of the submandibular gland in level I lymphadenectomy has been the standard. However, as functional dissection
procedures evolve, the routine removal of the submandibular
gland has been questioned.5,6 The submandibular gland contributes to the unstimulated production of saliva.7 Saliva plays
an important role in the preparation of the food bolus, lubrication of masticated food, exerting an antimicrobial effect in the
oral cavity and providing dental protection.8 Routine extirpation of the submandibular gland can aggravate the xerostomia
experienced by a vast majority of head and neck cancer
patients, particularly after adjuvant therapy. This results in
dental caries, gingivitis, periodontitis and osteonecrosis.9 Pharmaceutical agents have had limited success in relieving xerostomia.7,10 The preservation of an uninvolved gland while
ensuring a comprehensive clearance of level I lymph nodes
appears to be a reasonable approach to address this issue.
In an anatomical and clinicopathological review of the
lymphatics of the submandibular space in oral carcinomas,
DiNardo proposed division of lymph nodes into six groups,
namely preglandular, prevascular, retrovascular, retroglandular, intraglandular and deep submandibular. Regional metastasis was most commonly seen in the pre- and retrovascular
group of nodes. No intraglandular nodes were identiﬁed in any
of the clinical or cadaveric specimens,4 supporting the idea
that there is no risk of leaving lymph nodes behind when
sparing an uninvolved gland. Other studies have also shown
that submandibular glands themselves do not contain lymph
nodes4,11 and could be preserved without risking recurrence
or survival. However, there is evidence that preserving the
submandibular gland is not advisable in the ﬂoor of the mouth,
in tongue cancers and in T2 lesions.12,13
The objective of the present study was to determine the
incidence of submandibular gland metastases in oral cavity
carcinomas and to identify possible factors that may inﬂuence its involvement. A secondary objective was to determine the frequency of residual neck disease at level I.

Materials and Methods
The present study received exemption from the institutional
ethical review committee. A retrospective review of oral
carcinoma cases operated at our center between February 2017
and January 2018 was performed. Patients with histopathologically conﬁrmed squamous cell carcinoma of any of the
subsites of the oral cavity who underwent primary surgical
excision with ipsilateral and/or contralateral neck dissection
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with removal of at least one submandibular gland were
included. Patients with a prior history of surgery, radiation
or chemotherapy and those with histology other than squamous cell carcinoma were excluded. Medical records of 150
cases met the criteria.
In addition, the ﬁles of 36 patients, in whom level I dissection was performed leaving behind the submandibular gland,
were also reviewed. These patients were followed-up for
6 months for any evidence of residual disease following
preservation of the gland. Clinical examination and computed
tomography (CT) scan done at the completion of treatment
were used to evaluate the patients.
Data regarding age, gender, tumor site, neck nodal status
and staging was collected. Postoperative histopathological
reports were reviewed to record the involvement of the
submandibular gland. The presence of lymph nodes within
the gland and direct invasion of the gland were assessed.
Patient data was analyzed using IBM SPSS Statistics for
Windows, Version 23.0 (IBM Corp., Armonk, NY, USA). The
Fischer exact test was applied to identify signiﬁcant differences where relevant.

Results
During the study period of 1 year, 150 cases of oral carcinoma
met the study inclusion criteria. One case was excluded from
analysis due to a different ﬁnal histology, leaving 149
patients. A total of 169 neck dissections were recorded as
20 patients underwent bilateral neck dissections. Of these
20, the submandibular gland on the contralateral side was
also excised in 8 patients, giving a total of 157 submandibular
glands for evaluation.
There were 112 male (75.2%) and 37 female (24.8%)
patients. The mean age was 47.6  12.8 years old. The
most common primary subsite was the buccal mucosa
(n ¼ 94; 63.1%), followed by the tongue (n ¼ 33; 22.1%), the
gingiva (n ¼ 8; 5.4%), the hard palate (n ¼ 4; 2.7%), the retromolar trigone (n ¼ 4; 2.7%), the lips (n ¼ 3; 2.0%) and the ﬂoor
of the mouth (n ¼ 3; 2%). Patients most commonly presented
with stage IV disease (55.7%), followed by stage III (20.8%),
stage II (16.8%) and stage I (6.7%). Most patients presented
with a T4a tumor (n ¼ 60; 40.3%) (►Table 1). Lymph node
involvement was not found (pN0) in 79 (53%) of patients.
Neck metastasis was seen in 70 (47%) of patients, with pN2b
being the most common neck stage (26.8%). Occult metastases were seen in 22 out of 82 necks (26.8%).
Histopathology of the submandibular gland revealed that
7 out of 149 (4.7%) ipsilateral submandibular glands were
positive for metastases (►Table 2). Of the 8 contralateral
submandibular glands excised, none were positive.
Level I lymph nodes were positive in 47 out of 149 cases
(31.5%). All 7 patients with involvement of the submandibular gland had positive level I lymph nodes (►Table 3). Of these
7 patients, two had a single positive node at level I while 5
had multiple level I positive nodes. None of the 79 patients
with pN0 necks had gland involvement. Using the Fisher
exact test, this difference was found to be statistically
signiﬁcant (p < 0.01).
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Table 3 Level I positivity and submandibular gland involvement

Site

# of
cases

T1 (%)

T2 (%)

T3 (%)

T4 (%)

Buccal
mucosa

94

7
(7.4%)

29
(30.9%)

14
(14.9%)

44
(46.8%)

Tongue

33

4
(12.1%)

15
(45.5%)

13
(39.4%)

1
(3%)

Retromolar
trigone

4

–

2
(50%)

–

2
(50%)

Gingiva

8

2
(25%)

2
(25%)

–

4
(50%)

Floor of
the mouth

3

–

–

–

3
(100%)

Lips

3

–

–

1
(33.3%)

2
(66.7%)

Hard
palate

4

Total

149

Submandibular
gland involvement
Yes

No

7

40

Total

Level I positive
Yes

47

No

0

102

102

Total

7

142

149

157

mouth cases were T4 and had direct extension of the tumor
into the gland. The remaining 5 cases, that is, four buccal
mucosa and one gingivobuccal sulcus, had positive periglandular lymph nodes with extension into the gland. These
5 cases had 3 or more positive lymph nodes in level I.
An independent set of 36 patients in whom the submandibular gland was preserved was followed up to 6 months for
any residual or recurrent disease at level I. None of these
patients had any evidence of residual or recurrent disease in
the neck. The most common primary subsite amongst these
was the buccal mucosa (n ¼ 18; 50.0%) followed by the tongue
(n ¼ 13; 36.1%), the gingiva (n ¼ 4; 11.1%), and the ﬂoor of
the mouth (n ¼ 1; 2.8%). There were 9 patients with N1 neck
disease conﬁned to level I and 5 patients had N2 disease
involving level I and II. None of these had extra capsular
extension. The remaining 22 patients had N0 necks free of
any disease on the ﬁnal pathology (►Table 5).

Ipsilateral

7

Discussion

Contralateral

0

4
(100%)
13
(8.7%)

48
(32.2%)

28
(18.8%)

60
(40.3%)

Table 2 Involvement of submandibular gland
Total patients

149

Neck dissections
Unilateral

129

Bilateral

20

Total submandibular glands excised
Submandibular gland involved

Total (%)

7 (4.5%)

With regards to the primary sub-sites of the 7 cases with
involvement of the submandibular gland, 4 were from the
buccal mucosa, 2 from the ﬂoor of the mouth and one from
the gingivobuccal sulcus (►Table 4). The two ﬂoor of the

In a neck dissection, whether selective, modiﬁed or radical,
the excision of the submandibular gland is the standard
while dissecting lymph nodes from level IB. The frequency
of submandibular gland involvement in the literature ranges
from 0.6 to 4.5% and has 3 mechanisms (►Table 6). There
may be direct invasion of the gland by the tumor, invasion of
the submandibular gland by metastatic lymph nodes in level
I or by metastasis to intraglandular lymph nodes. Direct
invasion by the tumor has been reported to be the most

Table 4 Mechanism of invasion
Site

# of cases

Direct
invasion

Invasion through
metastatic lymph node

Metastasis to
submandibular gland

Total submandibular
gland involvement

Buccal mucosa

94

–

4

–

4

Tongue

33

–

–

–

0

Retromolar trigone

4

–

–

–

0

Gingiva

8

–

1

–

1

Floor of the mouth

3

2

–

–

2

Lips

3

–

–

–

0

Hard palate

4

–

–

–

0

Total

149

2

5

0

7
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Table 5 Regional recurrence according to N stage after
preservation of the submandibular gland
N Stage

# of cases

Recurrence

N0

22

0

N1

9

0

N2

5

0

Total

36

0

common method (►Table 6). In our study, the submandibular involvement was most commonly from metastatic level I
lymph nodes invading the gland.
In a review of 107 head and neck cancer cases, Ebrahim
et al found the submandibular gland to be involved in 1 case.8
However, this study included a smaller number of oral cavity
tumor cases (52), of which 8% had metastases up to level Ib.
The single case in which the gland was inﬁltrated by tumor
was a T3 buccal carcinoma that had gross involvement of the
gland by direct spread of the tumor. Basaran et al studied 236
patients undergoing neck dissections for oral carcinoma and
found 13 (5.5%) of the glands involved. Direct invasion was
again the most common mechanism in 8 out of the 13
positive glands. Four additional glands were inﬁltrated
from metastatic paraglandular lymphadenopathy. Almost
all of the cases in this series were tongue or ﬂoor of the
mouth carcinomas.5 In another study from the region, a
review of 98 specimens revealed involvement of the submandibular gland in 3 patients (3.06%). Submandibular
gland involvement was secondary to direct invasion in 2
cases where the primary lesion was in the tongue and in the
ﬂoor of the mouth; both were T4N2B lesions. Involvement
through metastatic periglandular lymph node was seen in 1
case of buccal mucosa tumor; also a T4N2b lesion.14
In our series, metastatic periglandular lymph node inﬁltration was more commonly encountered than direct tumor
invasion. Direct invasion was seen in 2 of the 157 (1.3%) glands.
Tumors involving the ﬂoor of the mouth (n ¼ 2) were the only
cases that directly invaded the gland. In one of the largest series
addressing submandibular gland inﬁltration in ﬂoor of the
mouth carcinomas, a re-review of pathology slides from 51
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ﬂoor of the mouth carcinoma cases was performed.15 Intraglandular lymph nodes were not found in any of 69 submandibular glands studied.
Junquera et al reported 31 cases of ﬂoor of the mouth
squamous cell carcinoma with an incidence of ipsilateral
level I metastasis of 31.7%, but there were no cases of
submandibular gland invasion.16 The authors therefore concluded that it is reasonable to preserve the gland when it is
not directly inﬁltrated by the tumor. Here, 5 cases (3.2%) are
reported in which the gland was inﬁltrated by adjacent
lymph node rather than tumor inﬁltration. This was the
most common mechanism of spread of tumor in the current
series. Of these 5 cases, 4 had > 3 positive lymph nodes,
whereas the remaining case had a single positive node at
level Ib. Level I positivity also appears to be an important
factor in determining the fate of the submandibular gland.
Based on the results reported here, preoperative or intraoperative ﬁnding of enlarged level I nodes would be a good
indicator for submandibular gland extirpation.
The presence of intraglandular lymph nodal metastasis
has been controversial.17 Very few studies have reported this
possibility. Chen et al reported one case of metastasis to the
submandibular gland.18 Vaidya et al reported two cases, one
of which was a tongue tumor, while the other was a palate
tumor.19 In our study, intraglandular lymphoid tissue as a
source of metastasis was not seen.
A major concern in submandibular gland-sparing neck
dissection is leaving behind a metastatic lymph node, as
nodal disease is a signiﬁcant prognostic indicator of poor
outcome. Chen et al reported survival rates for early T1 and
T2 N0 oral carcinomas in patients with and without submandibular gland preservation.13 Although no statistical
difference was found in the overall survival, there were only
10 patients with T2 oral carcinoma with preserved submandibular glands. Of these, 3 developed regional recurrence at level I and II, which may have been due to an
inadequate nodal dissection. In our experience of 36
patients with submandibular gland preservation, there
was no evidence of residual disease in the neck or early
regional recurrence
In a series of 66 cases of tongue and ﬂoor-of-mouth
cancers, Lanzer et al reported lymph node recurrence in

Table 6 Literature review of submandibular gland involvement according to mechanism
Authors

Siegel et al17
18

Total # of
submandibular
glands evaluated

Positive
submandibular
gland

196

Mechanism of submandibular gland involvement
Tumor invasion

Invasion by
metastatic
lymph node

Metastasis to
submandibular gland

9

6

3

–

383

7

5

1

1

22

153

1

1

–

–

Byeon et al23

316

2

2

–

–

294

13

8

4

1

157

7

2

5

–

Chen et al

Razfar et al

Basaran et al

5

Current study
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28.5% of the patients with preserved submandibular glands.
The study cohort largely comprised of T1 and T2 lesions
with N0 necks. The authors postulated that although lymphatics develop after the submandibular gland is encapsulated, lymphatic vessels can adhere to the gland capsule and
serve as a reservoir of cancer cells if the gland is
preserved.20
The decision whether or not to excise the submandibular
gland should be based on the proximity of the primary
tumor to the gland and the status of level I nodes.21 As
reported here, only cancers of the ﬂoor of the mouth had
direct tumor invasion and there was no invasion of the
submandibular gland in T1 and T2 lesions of other primary
sites and in N0 necks. Therefore, it would be prudent to
excise the gland when there are adherent pathologic lymph
nodes or a very close primary tumor.

Conclusion

6

7

8

9
10

11

12

Preservation of the submandibular gland during neck dissection in surgical management of oral carcinoma can be practiced safely when there is no evidence of direct extension of
primary tumor toward the submandibular gland or when
there is no clinical or radiological evidence of neck disease
in level I. Presence of pathological lymph nodes in level I
requires caution when contemplating preservation of the
submandibular gland. Sparing the submandibular gland
does not compromise oncologic clearance at level I, although
additional studies are required to investigate the effects of
submandibular gland preservation on survival and locoregional control of disease.
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